Xvivo Perfusion AB Asset Resilience Ratio

Latest as of December 2025: 12.30%

Xvivo Perfusion AB asset resilience ratio. Xvivo Perfusion AB (XVIVO) has an Asset Resilience Ratio of 12.30% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read XVIVO current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr292.09 Million
≈ $31.43 Million USD Cash + Short-term Investments

Total Assets

Skr2.37 Billion
≈ $255.49 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of Xvivo Perfusion AB (2016–2025)

Asset resilience ratio of Xvivo Perfusion AB from 2016 to 2025. This chart shows how Xvivo Perfusion AB's Asset Resilience Ratio has changed over time. See Xvivo Perfusion AB (XVIVO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Xvivo Perfusion AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Xvivo Perfusion AB's balance sheet.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents Skr292.09 Million 12.3%
Short-term Investments Skr0.00 0%
Total Liquid Assets Skr292.09 Million 12.30%

Asset Resilience Insights

  • Moderate Liquidity: Xvivo Perfusion AB has 12.30% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Xvivo Perfusion AB Industry Peers by Asset Resilience Ratio

Compare Xvivo Perfusion AB's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
GN Store Nord
CO:GN
Medical Devices -4.56%
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
Medical Devices 6.09%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
VIROMED MEDICAL NA O.N.
XETRA:VME
Medical Devices 0.03%
Affluent Medical SAS
PA:AFME
Medical Devices 0.03%
DRGEM Corporation
KQ:263690
Medical Devices 2.12%

Xvivo Perfusion AB Asset Resilience Ratio by Year (2016–2025)

Xvivo Perfusion AB asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Xvivo Perfusion AB.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2025-12-31 12.30% Skr292.09 Million
≈ $31.43 Million
Skr2.37 Billion
≈ $255.49 Million
-4.98pp
2024-12-31 17.28% Skr415.22 Million
≈ $44.68 Million
Skr2.40 Billion
≈ $258.57 Million
-21.25pp
2023-12-31 38.54% Skr846.09 Million
≈ $91.05 Million
Skr2.20 Billion
≈ $236.28 Million
+20.19pp
2022-12-31 18.34% Skr317.86 Million
≈ $34.21 Million
Skr1.73 Billion
≈ $186.51 Million
-7.51pp
2021-12-31 25.85% Skr398.70 Million
≈ $42.91 Million
Skr1.54 Billion
≈ $166.01 Million
-4.95pp
2020-12-31 30.79% Skr354.24 Million
≈ $38.12 Million
Skr1.15 Billion
≈ $123.79 Million
+5.59pp
2019-12-31 25.21% Skr159.95 Million
≈ $17.21 Million
Skr634.49 Million
≈ $68.28 Million
-6.68pp
2018-12-31 31.89% Skr187.06 Million
≈ $20.13 Million
Skr586.61 Million
≈ $63.13 Million
-4.38pp
2017-12-31 36.27% Skr195.32 Million
≈ $21.02 Million
Skr538.54 Million
≈ $57.96 Million
+29.15pp
2016-12-31 7.12% Skr24.87 Million
≈ $2.68 Million
Skr349.30 Million
≈ $37.59 Million
--
pp = percentage points

About Xvivo Perfusion AB

ST:XVIVO Sweden Medical Devices
Market Cap
$694.92 Million
Skr6.46 Billion SEK
Market Cap Rank
#10233 Global
#174 in Sweden
Share Price
Skr205.00
Change (1 day)
+0.39%
52-Week Range
Skr162.40 - Skr309.00
All Time High
Skr539.00
About

Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates through Thoracic; Abdominal; Services; and other segments. The company offers Kidney Assist Transport, a portable device that allows hypothermic pulsatile perfusion of donor kidn… Read more